Concepedia

Jennifer Dumont

JD

42

Publications

3.9K

Citations

32

H-Index

1986

Active since

Affiliations

Biogen (United States)(Current)

Tonix Pharmaceuticals (United States)

University of Pittsburgh

Indiana Hemophilia and Thrombosis Center

Hospital for Sick Children

Jennifer Dumont is an author at Biogen (United States) specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1986–2023

42

Publications

42

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A

Johnny Mahlangu, Jerry S. Powell, Margaret V. Ragni et al. · Blood · 2013 · 436 citations · Full text

Receptor-mediated Immunoglobulin G Transport Across Mucosal Barriers in Adult Life

Gerburg M. Spiekermann, Patricia W. Finn, E. Sally Ward et al. · The Journal of Experimental Medicine · 2002 · 393 citations · Full text

, , +24

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 347 citations · Full text

Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients

Jerry S. Powell, Neil C. Josephson, Doris Quon et al. · Blood · 2012 · 230 citations · Full text

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

Alan J. Bitonti, Jennifer Dumont, Susan C. Low et al. · Proceedings of the National Academy of Sciences · 2004 · 227 citations · Full text

Rows per page

1–5 of 42